The report "Hemodialysis and Peritoneal Dialysis Market by Product (Machine, Bloodline, Concentrate (Alkaline), Catheter, Dialyzer, Water Treatment, Services), Modality (CAPD, Nocturnal), User (Hospital, Home Care) - Global Forecast to 2029", is projected to reach USD 126.2 billion by 2029 from USD 92.0 billion in 2024 at a CAGR of 6.5% during the forecast period.
Download
PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1279
Browse
- 150 Market Data Tables
- 65 Figures
- 350 Pages and in-depth TOC on " Hemodialysis
and Peritoneal Dialysis Market - Global Forecast to 2029”
Some of the prominent key players are:
- Fresenius Medical Care AG & Co. KGaA
(Germany),
- Baxter International Inc. (US),
- Nipro Corporation (Japan),
- NIKKISO CO., LTD. (Japan), and many
more......
Mergers & acquisitions, investments & expansions,
partnerships & collaborations, and new product developments are some of the
major strategies adopted by these key players to enhance their positions in the
Hemodialysis and Peritoneal Dialysis Market .
Growth
Driver: Rising prevalence of chronic kidney disease globally
The
rising prevalence of chronic kidney disease (CKD) globally is expected to
significantly drive the hemodialysis and peritoneal dialysis market. Chronic
kidney disease is likely to affect more than 10% of the population worldwide as
chronic kidney disease becomes more prevalent due to factors such as aging
populations, increasing rates of diabetes and hypertension, increasing the CKD
progression to end-stage renal diseases, necessitating the dialysis. Chronic
kidney disease (CKD) is more prevalent among individuals aged 65 years or
older. According to Centres of Disease Control and Prevention (CDC), an
estimated 35.5 million people in US were diagnosed with CKD in 2023.
Opportunity:
High growth potential of emerging markets
Emerging
markets such as China, India, Brazil, are expected to offer significant growth
opportunities for players operating in the POC diagnostics market. This is
primarily due to the high and growing prevalence of diabetes, chronic kidney
diseases, in these countries. As economic growth in China and India continues
to expand, there is rise in healthcare spending across these countries, which
leads to improved affordability of hemodialysis and peritoneal dialysis
treatment. According to the article published by BMC Nephrology in 2023, in
China, the prevalence of ESRD is projected to reach 1,505 patients per million
population by 2025. To meet the increasing demand for dialysis in the emerging
markets, players focus on acquiring or entering into agreements and
partnerships with healthcare providers.
- The hemodialysis market is segmented
based on product and service. Hemodialysis products include hemodialysis
machines and hemodialysis consumables & supplies, whereas hemodialysis
services include in-center services and home services. The hemodialysis
services segment is anticipated to grow at significant rate during the
forecast period.
- Based on end users, home care setting is
expected to grow at a significant rate owing to growing preference of
patients for home hemodialysis modality, technological advancements, and
the cost-effectiveness of home dialysis treatment over incentre dialysis
procedures.
- On the basis of region, the hemodialysis
and peritoneal dialysis market is segmented into North America, Europe,
Asia Pacific, and the Latin America, Middle East & Africa. The
Asia-Pacific market is likely to witness significant market growth. This is
attributed to the rise in geriatric patient population, increasing cases
of chronic kidney diseases, moreover improving healthcare infrastructure
and the implementation of supportive government initiatives to increase
the accessibility of dialysis services in many APAC countries such as
India and China.
Recent
Developments of Hemodialysis and Peritoneal Dialysis Industry:
- In July 2023, Rockwell Medical acquired
the hemodialysis concentrates business from Evoqua Water Technologies,
strengthening its presence in the hemodialysis market
- In January 2022, Nextkidney BV acquired
Dialyss Pte Ltd, enhancing its technology capabilities in home
hemodialysis
- In March 2021, DaVita Inc. signed an
agreement with Fresenius Medical Care AG & Co. KGaA for the expansion
of the usage of NxStage Home Hemodialysis Machines
The escalating global prevalence of chronic
kidney disease, spurred by growing aging population coupled with the increasing
cases of diabetes and hypertension are fuelling the demand for renal
replacement therapy including hemodialysis and peritoneal dialysis products and
services. Ongoing technological advancements in dialysis technology, growing
patient preference of home dialysis, supporting reimbursement policies and
government initiatives and funding for healthcare infrastructure, enabling
expansion of hospitals and dialysis centers further enhancing the accessibility
of hemodialysis and peritoneal dialysis services among patients with end-stage
renal disease (ESRD) are likely to drive the market growth during the forecast
period.
Related News :-
No comments:
Post a Comment